Arash Pakseresht
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 2%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 11
- Diabetes Management and Research 3
-
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- Sue D. Pedersen (4 shared papers)Leigh Perreault (3 shared papers)Louise Færch (3 shared papers)Julio Rosenstock (2 shared papers)Melanie J. Davies (3 shared papers)Ildiko Lingvay (3 shared papers)Adie Viljoen (3 shared papers)Thomas A. Wadden (3 shared papers)
- Journals
- Canadian Journal of Diabetes (3 papers)Obesity Research & Clinical Practice (1 paper)Obesity (1 paper)The Lancet (1 paper)Value in Health (1 paper)
- Partner nations
- DenmarkUnited KingdomUnited States
In The Last Decade
Arash Pakseresht
11 papers receiving 1.0k citations
Arash Pakseresht's Hit Papers
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 642
- Pharmacology 314
- Pharmacy 66
- Physiology 197
- Surgery 180
Countries citing papers authored by Arash Pakseresht
This map shows the geographic impact of Arash Pakseresht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Pakseresht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Pakseresht more than expected).
Fields of papers citing papers by Arash Pakseresht
This network shows the impact of papers produced by Arash Pakseresht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Pakseresht. The network helps show where Arash Pakseresht may publish in the future.
Co-authors
The 25 scholars most cited alongside Arash Pakseresht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 879 |
| 2 | 2019 | 63 | |
| 3 | 2019 | 59 | |
| 4 | 2020 | 21 | |
| 5 | 2016 | 7 | |
| 6 | 2020 | 6 | |
| 7 | 2019 | 6 | |
| 8 | 2016 | 4 | |
| 9 | 2016 | 4 | |
| 10 | 2021 | 2 | |
| 11 | 2018 | 2 | |
| 12 | 2021 | 1 |
About Arash Pakseresht
Arash Pakseresht is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pharmacology and Neurology, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (11 papers), Metabolism, Diabetes, and Cancer (4 papers), Diabetes Management and Research (3 papers), Pharmacology and Obesity Treatment (3 papers), Pancreatic function and diabetes (2 papers), Obesity, Physical Activity, Diet (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (642 citations), Pharmacology (314 citations), Pharmacy (66 citations), Physiology (197 citations) and Surgery (180 citations). Arash Pakseresht has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Sue D. Pedersen, Leigh Perreault, Louise Færch, Julio Rosenstock, Melanie J. Davies, Ildiko Lingvay, Adie Viljoen, Thomas A. Wadden, Iichiro Shimomura and Ole Kleist Jeppesen. Their work appears in journals such as Canadian Journal of Diabetes, Obesity Research & Clinical Practice, Obesity, The Lancet and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.